The value of 18F-PSMA-1007 PET/CT in evaluating oligometastatic and curative effects of prostate cancer
- VernacularTitle:18F-PSMA-1007 PET/CT在前列腺癌寡转移与疗效评估中的价值
- Author:
Zhuonan WANG
1
;
Anqi ZHENG
1
;
Jungang GAO
1
;
Yang LI
1
;
Xiang LIU
1
;
Xiaoyi DUAN
1
Author Information
- Publication Type:Journal Article
- Keywords: prostate cancer; oligometastasis; prostate-specific membrane antigen; PET/CT; SUVmax
- From: Journal of Xi'an Jiaotong University(Medical Sciences) 2022;43(2):168-172
- CountryChina
- Language:Chinese
- Abstract: 【Objective】 To investigate the value of prostate-specific antigen (PSA) level, Gleason score, and PSMA PET/CT maximum standardized uptake value (SUVmax) in predicting prostate cancer (PCa) metastasis and the treatment option of oligometastatic PCa. 【Methods】 We retrospectively recruited 170 patients with PCa confirmed by pathology, 97 of whom were untreated, and divided them into nonmetastatic group, oligometastatic group (metastasis≤5), and polymetastatic group. In addition, 28 patients with oligometastatic PCa underwent radical prostatectomy and 45 patients underwent androgen-deprivation therapy. We compared the differences in SUVmax, PSA, and Gleason scores between the three sub-groups of untreated patients, and also analyzed the correlation between SUVmax of local cancer lesions, Gleason score and PSA level. We further compared the differences in SUVmax and PSA levels between radical prostatectomy and androgen-deprivation therapy of oligometastatic PCa patients. According to Gleason score, patients with oligometastatic PCa were divided into two groups (low-intermediate risk group with Gleason score ≤7 and high-risk group with Gleason score ≥8), and the levels of SUVmax and PSA between the groups were compared. 【Results】 With the increasing number of metastases, SUVmax, PSA levels and Gleason scores all showed an upward trend, and there were significant differences among the three groups (P=0.029, P=0.001, P=0.046). The post-hoc test found significant difference in Gleason score between the oligometastatic group and the other two groups (P=0.043, P=0.002) as well as correlation of SUVmax level of the primary tumor with Gleason score and PSA (P=0.002, r=0.315; P<0.001, r=0.430). There was significant difference in PSA level between the two groups after radical prostatectomy and androgen-deprivation therapy (P=0.017). The difference in PSA between the two treatments persisted in the low-intermediate risk groups (P=0.021). 【Conclusion】 PSA level, Gleason score and SUVmax have some value in predicting PCa metastasis. Radical prostatectomy is an effective treatment strategy for patients with oligometastatic PCa, especially those with low-intermediate Gleason score.